Cepheid Logo
Request Info
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

{{initials}}
Main Menu
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Request Info

Xpert® Mpox

Mpox computer generated depiction.
On-demand Mpox testing provides qualitative point-of-care results in approximately 36 minutes, with EAT results as soon as 25 minutes. For use under an Emergency Use Authorization in the United States

The Need

an ill woman listens to a physician
Human mpox disease was first observed in 1970 in the Democratic Republic of the Congo and two clades have been described; clade I (formerly Congo Basin) and clade II (formerly West African).1,2 Cases were mostly limited to Central and West Africa until the outbreak in 2022 caused by mpox clade II. Within 6 months >80,000 cases were reported in more than 100 countries; approximately 30% of cases were identified in the US.3
PCR-based test results are needed on the same day of visit to support clinical management and public health reporting.
Challenges
  • Limited availability of same‑day results can create challenges for clinical management and public health response
  • Challenges associated with distinguishing mpox from other causes of cutaneous lesions
  • Testing options that offer accurate and objective test results to drive timely and appropriate treatment for improved patient management
  • Lack of flexibity to run tests on demand with scalable throughput
1Monkeypox: experts give virus variants new names. Accessed Jan 6, 2023.Monkeypox: experts give virus variants new names (who.int)
2 McCollum AM, Damon IK. Human Monkeypox. Clin Infect Dis. 2014 Jan;58(2):260-7. doi: 10.1093/cid/cit703.
32022 Mpox Outbreak Global Map | Mpox | Poxvirus | CDChttps://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.htmlaccessed 6 jan 2023

Connect To Better Outcomes

Request Info

Insights

Get more Insight